More than skin deep? Emerging therapies for chronic cutaneous GVHD

Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease

(2011) William R. Drobyski et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized Study

(2011) Hildegard T. Greinix et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Improvement in Oral Chronic Graft-versus-Host Disease with the Administration of Effervescent Tablets of Topical Budesonide—An Open, Randomized, Multicenter Study

(2011) Sharon Elad et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

(2011) F L Dignan et al.   BONE MARROW TRANSPLANTATION

German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD

(2011) C. Marks et al.   BRITISH JOURNAL OF DERMATOLOGY

Mesenchymal Stromal Cells for Graft-Versus-Host Disease

(2011) Jakub Tolar et al.   HUMAN GENE THERAPY

Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD

(2010) Daniel Wolff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

(2010) Daniel Wolff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea

(2010) E. Antiga et al.   BRITISH JOURNAL OF DERMATOLOGY

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study

(2010) S. J. Kim et al.   HAEMATOLOGICA

UVA1 phototherapy: a review of mechanism and therapeutic application

(2010) Nathan R. York et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Effects of Pravastatin on Murine Chronic Graft-Versus-Host Disease

(2010) Hyoung-Kyu Yoon et al.   TRANSPLANTATION

Clinical Utility of Rituximab in Chronic Graft-Versus-Host Disease

(2009) Jill S Bates et al.   ANNALS OF PHARMACOTHERAPY

Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies

(2009) J H W Distler et al.   ANNALS OF THE RHEUMATIC DISEASES

Many faces of graft-versus-host disease

(2009) Pablo F Peñas et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Induction of Lethal Graft-versus-Host Disease by Anti-CD137 Monoclonal Antibody in Mice Prone to Chronic Graft-versus-Host Disease

(2009) Wonyoung Kim et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis

(2009) Mohamed A. Kharfan-Dabaja et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study

(2009) D. A. Jacobsohn et al.   BLOOD

Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease

(2009) L. Magro et al.   BLOOD

Imatinib for refractory chronic graft-versus-host disease with fibrotic features

(2009) A. Olivieri et al.   BLOOD

The role of B cells in the pathogenesis of graft-versus-host disease

(2009) A. Shimabukuro-Vornhagen et al.   BLOOD

Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients

(2009) V. Brazzelli et al.   BRITISH JOURNAL OF DERMATOLOGY

Extracorporeal photopheresis: what is it and when should it be used?

(2009) J. Scarisbrick   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Regulatory T Cells and Extracorporeal Photochemotherapy: Correlation With Clinical Response and Decreased Frequency of Proinflammatory T Cells

(2009) Iolanda Di Biaso et al.   TRANSPLANTATION

Imatinib as a Potential Treatment for Sclerodermatous Chronic Graft-vs-Host Disease

(2008) Juan A. Moreno-Romero   ARCHIVES OF DERMATOLOGY

The thymus in GVHD pathophysiology

(2008) Werner Krenger et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Therapy of chronic graft-versus-host disease

(2008) Mukta Arora   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

(2008) M. E. D. Flowers et al.   BLOOD

Alefacept treatment for refractory chronic extensive GVHD

(2008) M Y Shapira et al.   BONE MARROW TRANSPLANTATION

Immune modulation and chronic graft-versus-host disease

(2008) R J Soiffer   BONE MARROW TRANSPLANTATION

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

(2008) J.J. Scarisbrick et al.   BRITISH JOURNAL OF DERMATOLOGY

Cutaneous Graft-versus-Host Disease: A Guide for the Dermatologist

(2008) Peter Häusermann et al.   DERMATOLOGY

B-cell involvement in chronic graft-versus-host disease

(2008) R. Kapur et al.   HAEMATOLOGICA

Ultraviolet A phototherapy for sclerotic skin diseases: A systematic review

(2008) Elisabeth B.M. Kroft et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET